$10.41
+0.80 (+8.32%)
Open$9.78
Previous Close$9.61
Day High$10.59
Day Low$9.58
52W High$26.50
52W Low$2.57
Volume—
Avg Volume61.8K
Market Cap286.26M
P/E Ratio—
EPS$-0.13
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 28.41M | 28.26M | 24.54M |
| Net Income | 5.07M | 4.33M | 4.07M |
| Profit Margin | 17.8% | 15.3% | 16.6% |
| EBITDA | 7.12M | 6.76M | 5.89M |
| Free Cash Flow | 5.68M | 5.26M | 4.99M |
| Rev Growth | +18.7% | -2.9% | -7.4% |
| Debt/Equity | 0.72 | 0.77 | 0.81 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |